VEG-HM065-100μg / 询价
VEG-HM065-500μg / 询价
VEG-HM065-500μgx2 / 询价
Human VEGF165 Protein
Recombinant Human VEGF165 Protein is expressed from HEK293 without tag. It contains Ala27-Arg191.[Accession | P15692-4]
The protein has a predicted MW of 19.2 kDa. Due to glycosylation, the protein migrates to 20-30 kDa based on Tris-Bis PAGE result.
Less than 1EU per μg by the LAL method.
> 95% as determined by Tris-Bis PAGE
> 95% as determined by HPLC
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
-20 to -80°C for 12 months as supplied from date of receipt.
-80°C for 3-6 months after reconstitution.
2-8°C for 2-7 days after reconstitution.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Human VEGF165 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Human VEGF165 is greater than 95% as determined by SEC-HPLC.
Immobilized Human VEGF165 at 1μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Human VEGFR1, His Tag with the EC50 of 46.4ng/ml determined by ELISA (QC Test).
Immobilized Human VEGF165 at 1μg/ml (100μl/well) on the plate. Dose response curve for Human VEGFR2, mFc Tag with the EC50 of 42.3ng/ml determined by ELISA.
Human VEGF165 stimulates proliferation of human umbilical vein endothelial cells (HUVEC) with the ED50 for this effect is 2.57ng/mL (QC Test).
Human papillomavirus (HPV) infection is an established risk factor for cervical carcinogenesis. VEGF165 was significantly higher, whereas VEGFC and VEGFD were significantly lower in malignant cervical carcinoma tissues as compared to normal cervix tissues. Expression levels of VEGF121 and VEGFC were significantly associated with type of tumor growth while VEGF165 was significantly associated with lymph node metastasis.
VEGF; VEGFA; MVCD1; VAS; VEGFMGC70609; VPF; RP1-261G23.1; MGC70609;VEGF-165
(1) Patel KA, Patel BM, Thobias AR, Gokani RA, Chhikara AB, Desai AD, Patel PS. Overexpression of VEGF165 is associated with poor prognosis of cervical cancer. J Obstet Gynaecol Res. 2020 Nov;46(11):2397-2406. doi: 10.1111/jog.14483. Epub 2020 Sep 27. PMID: 32985053.
